Semax is a synthetic peptide derived from fragments of adrenocorticotropic hormone (ACTH) and has become a significant subject within neuropeptide research. Originally developed to support investigations into brain signaling pathways, it is frequently studied for its relationship to neuroprotective environments and cognitive-processing frameworks. Its structural stability allows researchers to evaluate peptide influence across complex neurological models. Scientific interest in Semax has expanded into areas involving neurotransmitter regulation, synaptic plasticity, and adaptive brain response mechanisms. Laboratories continue exploring how neuroactive peptides may contribute to resilience within demanding cellular environments. As neuroscience advances toward pathway-based understanding, Semax remains a prominent compound for researchers focused on cognitive-system signaling and neurological performance models.